# Merck sales rise 5% as quarterly earnings decline

> Merck reported third-quarter worldwide sales of 18.085 billion dollars on 29 October, up 5% from a year earlier, or 4% excluding currency effects.

- Canonical URL: https://newsverum.com/en/news/merck-third-quarter-2026-sales-earnings-outlook
- Publisher: Newsverum
- Section: Business
- Country: United States
- Published: 2026-10-29T15:53:56+00:00
- Updated: 2026-10-29T15:53:56+00:00
- Event / data period: 2026-09-30
- Other editions: [Türkçe](https://newsverum.com/tr/news/merck-third-quarter-2026-sales-earnings-outlook.md), [العربية](https://newsverum.com/ar/news/merck-third-quarter-2026-sales-earnings-outlook.md), [Français](https://newsverum.com/fr/news/merck-third-quarter-2026-sales-earnings-outlook.md), [Español](https://newsverum.com/es/news/merck-third-quarter-2026-sales-earnings-outlook.md), [Deutsch](https://newsverum.com/de/news/merck-third-quarter-2026-sales-earnings-outlook.md), [Português](https://newsverum.com/pt/news/merck-third-quarter-2026-sales-earnings-outlook.md)

Merck reported third-quarter worldwide sales of 18.085 billion dollars on 29 October, up 5% from a year earlier, or 4% excluding currency effects. Net income attributable to the company fell 12% to 5.065 billion dollars, while diluted earnings per share declined to 2.04 dollars from 2.32 dollars.

Non-GAAP net income was 6.159 billion dollars, down 4%, and non-GAAP earnings per share fell 3% to 2.49 dollars. Both reported and non-GAAP earnings included a one-time charge of 0.12 dollars per share relating to a global licensing agreement with SciBrunch. The adjusted measure does not remove every one-off expense.

The company forecast full-year sales of 66.8–67.3 billion dollars and non-GAAP earnings of 2.77–2.82 dollars per share. The annual outlook is distinct from results for the quarter ended 30 September 2026. Merck’s non-GAAP measure excludes specified acquisition, divestiture, restructuring and investment-related items, so it should be read alongside reported results.

## Data

### Source publication

Publication of the official announcement on 29 October 2026.

Methodology: The date records publication of the cited primary source. Statistical reference periods and announced future actions are identified in the article.

| date | label | description | status |
|---|---|---|---|
| 2026-10-29 | Merck sales rise 5% as quarterly earnings decline | Merck reported third-quarter worldwide sales of 18.085 billion dollars on 29 October, up 5% from a year earlier, or 4% excluding currency effects. Net income attributable to the company fell 12% to 5.065 billion dollars, while diluted earnings per share declined to 2.04 dollars from 2.32 dollars. | occurred |

Sources: <https://www.msd.com/news/merck-co-inc-rahway-n-j-usa-announces-third-quarter-2026-financial-results-highlights-multiple-milestones-advancing-broad-diverse-pipeline/> · Download data: [JSON](https://newsverum.com/api/v1/articles/merck-third-quarter-2026-sales-earnings-outlook/data/source-announcement?lang=en&format=json) · [CSV](https://newsverum.com/api/v1/articles/merck-third-quarter-2026-sales-earnings-outlook/data/source-announcement?lang=en&format=csv)

## Sources

- [Merck & Co., Inc. / MSD](<https://www.msd.com/news/merck-co-inc-rahway-n-j-usa-announces-third-quarter-2026-financial-results-highlights-multiple-milestones-advancing-broad-diverse-pipeline/>) (Source checked: 2026-10-29; Published: 2026-10-29)

---

Cite the canonical URL above. [Editorial standards and corrections](https://newsverum.com/en/editorial)
